French firm to launch first non-Japanese Hib vaccine in Japan
Written by Writer on Tuesday, October 14th, 2008
French firm to launch first non-Japanese Hib vaccine in Japan
HONK KONG (Kyodo) A meningitis vaccine manufactured by a France-based company will be delivered to Japan’s private health-care market by December, the company’s top official said in Hong Kong on Monday.
“It will be the first vaccine licensed by a multinational firm (that is being used) in Japan,” Wayne Pisano, president of Sanofi Pasteur, said in reference to the vaccine for Hib — Haemophilus influenzae type b infection.
Pisano said the vaccine has been used in other countries, but requirements in Japan against vaccines are strict and take a long time to get final approval.
According to the World Health Organization, Hib is a bacterium estimated to be responsible for some 3 million serious illnesses and an estimated 386,000 deaths per year worldwide.
The infectious disease mainly affects children under the age of 5, chiefly through meningitis and pneumonia, the WHO said.
The Japanese authorities have received the first batch of vaccines, Pisano said, adding that about 500,000 shots of the French vaccines will be available each year.
To save on labor cost and expand vaccination usage in China, the company is also building a 70 million euro ($95.2 million) manufacturing base in southern China’s Shenzhen, in addition to its filling and packaging facility already in operation.
The new site, to start operation by 2012, will focus on making influenza vaccines with an initial annual capacity of 25 million doses.
Pisano also said the Shenzhen production facility could be turned into producing pandemic vaccines, such as one for human infections of the often deadly bird flu virus H5N1, “in a matter of weeks.”
News Topics Related Posts :
- Dutch POW to receive A-bomb health benefits (Thursday, November 13, 2008)
- Israeli shipper to pay families over crewmen’s deaths (Thursday, November 13, 2008)
- New navi works underground (Thursday, November 13, 2008)
- Governors fight dam plan (Wednesday, November 12, 2008)
- Sukhothai bird flu outbreak under control (Tuesday, November 11, 2008)
- Ma aiming for WHA observer status (Sunday, November 9, 2008)
- Main works of Three Gorges Project finished a year ahead of schedule (Thursday, October 30, 2008)
- No room for complacency about bird flu (Thursday, October 30, 2008)
- Africa bird flu risks remain (Thursday, October 30, 2008)
- Nasty jab against bird flu research (Tuesday, October 28, 2008)
- Southern China factories to shed millions of jobs (Saturday, October 25, 2008)
- Can Spurs stop the bleeding? (Friday, October 24, 2008)
- Confessed lottery killer used money for debts (Friday, October 24, 2008)
- Ship, trawler collide; three fishermen killed (Friday, October 24, 2008)
- Tainted Cup Noodles sicken Fujisawa woman (Friday, October 24, 2008)
- Nagoya train starts day by derailing; no injuries (Friday, October 24, 2008)
- 5th China-ASEAN Expo opens in southern China city (Wednesday, October 22, 2008)
- The southern Chinese city of Guilin woos visitors with waterfalls and boat cruise (Wednesday, October 22, 2008)
- Plantation stocks higher at mid-day (Tuesday, October 21, 2008)
- Plans to produce new Subaru model outside Japan (Tuesday, October 21, 2008)
News Topics : Bird Flu, Bird Flu Virus, French Firm, Haemophilus Influenzae Type, Haemophilus Influenzae Type B, Health Care Market, Hib Vaccine, Honk Kong, Human Infections, Influenza Vaccines, Japanese Authorities, Kyodo, Meningitis Vaccine, Multinational Firm, Pisano, Private Health Care, Sanofi Pasteur, Southern China, Virus H5n1, World Health Organization
This entry was posted
on Tuesday, October 14th, 2008 and is filed under
Japan News.
You can follow any responses to this entry through the
RSS 2.0 feed.
You can
leave a response, or
trackback from your own site.